Rangen | AI Transformation Index
Rangen is a structurally durable business in the AI era precisely because its core value is physical — manufactured feed cannot be substituted by AI, and t...

Overview
Rangen manufactures and sells science-formulated animal feed and nutritional products — primarily for aquaculture, livestock, pet, and lifestyle animals — generating revenue through cost-plus product sales from its manufacturing facilities in Idaho and Texas.
Executive Summary
Rangen is a structurally durable business in the AI era precisely because its core value is physical — manufactured feed cannot be substituted by AI, and the plant infrastructure, regulatory certifications, and formulation IP create real barriers to AI-native competition. However, Balmoral should not expect AI to be a transformative lever for this asset: the production function is predominantly physical, the cognitive labor pool is small, and the realistic AI upside is concentrated in supply chain and formulation optimization rather than step-change business model transformation. This is a hold-for-durability story, not a buy-for-AI-transformation story.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
55.1
Ciridae AI Score
Durability Rationale
Rangen's durability rests on the most fundamental moat in this framework: the customer outcome is a physical product that AI cannot digitally substitute or deliver. Animal feed manufacturing requires capital-intensive plants, regulated supply chains, certified formulation processes, and physical distribution — none of which an AI-native entrant can replicate with software alone. The first-in-US ASC certification adds a meaningful regulatory differentiation layer in the high-value aquaculture segment. The primary durability risk is competitive — large multinational feed companies with more resources could use AI-assisted formulation or procurement optimization to sharpen their cost position — but this is a competitive pressure question, not an existential AI disruption question.
Opportunity Rationale
AI's reach into Rangen is genuinely limited by the physical nature of the business — most of what Rangen does is manufacturing, not cognitive labor. The realistic AI opportunity lives in formulation optimization, supply chain planning, and precision nutrition analytics, but these are meaningful improvements at the margin rather than a step-change transformation. Rangen lacks the large manual cognitive workforce that makes companies like insurance TPAs or medical review firms high-opportunity targets; its workers are primarily in production, maintenance, and transportation. The domain intelligence in aquaculture nutrition is real but not yet being applied at the volume and decision frequency that would make AI amplification a dramatic value driver.
Key Risks
Large multinational competitors (Cargill, Skretting, BioMar) deploy AI-powered formulation and procurement optimization at scale, achieving significant cost advantages that erode Rangen's pricing power in a cost-plus market — not because AI substitutes the outcome, but because it widens the competitive cost gap.
The formulation intelligence and domain expertise at Rangen is shallower or more codified than assumed — if general-purpose AI tools can replicate most of Rangen's nutritional science from public research and regulatory data, the O4 amplification thesis collapses and there is little differentiated AI value to unlock.
Company Overview
| Headquarters | Buhl, Idaho, United States |
| Products / Services | Aquaculture feeds, livestock feed, pet nutrition products, and specialized material handling services |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
An affiliate of Balmoral Funds LLC acquired Wilbur-Ellis Nutrition, LLC, which now operates under the Rangen brand. August 26, 2025 | Balmoral Funds acquired Wilbur-Ellis Nutrition for approximately $410 million [Balmoral Funds Acquisition Announcement, 2025](https://www.balmoralfunds.com/an-affiliate-of-balmoral-funds-llc-acquires-wilbur-ellis-nutrition-llc). |
Wilbur-Ellis Nutrition acquired the assets of Rangen, Inc. November 6, 2019 | Wilbur-Ellis Nutrition acquired Rangen, Inc. to expand its aquaculture and livestock feed offerings [PR Newswire Wilbur-Ellis Acquisition Announcement, 2019](https://www.prnewswire.com/news-releases/wilbur-ellis-nutrition-acquires-assets-of-rangen-inc-significantly-expanding-in-aquaculture-livestock-nutrition-sectors-300953190.html). |
Executives
| Name | Background |
|---|---|
Mark G. Essig CEO | Over 30 years of senior leadership experience across multiple industries, including manufacturing, distribution, and specialty materials [Mark Essig LinkedIn Profile](https://www.linkedin.com/in/mark-essig-ceo2022). |
Graham McDonough CFO | CFO and VP of Finance at Rangen Group since late 2025 [Graham McDonough LinkedIn Profile](https://linkedin.com/in/graham-mcdonough-7857b74a). |
Craig Augustine Senior Director of Operations | Extensive experience in operations leadership, previously serving as Director of Operations at Wilbur-Ellis [Craig Augustine LinkedIn Profile](https://linkedin.com/in/craig-augustine-69313195). |
Balmoral Funds